1. Control of src kinase activity by activators, inhibitors, and substrate chaperones;Abdel-Ghany;Proc. Natl. Acad. Sci,1990
2. Targeting tyrosine kinases in cancer: The second wave;Baselga;Science,2006
3. Covalent capture of kinase-specific phosphopeptides reveals Cdk1-cyclin B substrates;Blethrow;Proc. Natl. Acad. Sci,2008
4. A new paradigm for protein kinase inhibition: Blocking phosphorylation without directly targeting ATP binding;Bogoyevitch;Drug Discov. Today,2007
5. Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug;Capdeville;Nat. Rev. Drug Discov,2002